Show All
Show all
Cardlytics can be contacted via email at
Cardlytics makes marketing more relevant and measurable through our Purchase Intelligence platform. With purchase data from financial institutions, we have a secure view into where and when consumers are spending their money – both online and in-store. Cardlytics applies advanced analytics to this massive data set to create actionable Purchase Intelligence that benefits banks, marketers and consumers.
Shares of Cardlytics are traded on the Nasdaq Stock Market under the ticker symbol “CDLX.”
Cardlytics’ headquarters are located at 675 Ponce de Leon Avenue NE, Suite 6000, Atlanta, Georgia 30308, United States.
Cardlytics was formed in 2008 and is incorporated in Delaware.
Cardlytics’ transfer agent is American Stock Transfer & Trust Company, LLC, which can be contacted at
Cardlytics common stock can be purchased on the open market through any registered broker.
Cardlytics does not expect to declare or pay any cash or other dividends on its common stock in the near future, as Cardlytics intends to retain all available funds and any future earnings for the operation and expansion of its business.
All questions regarding ownership of Cardlytics stock should be addressed to the appropriate transfer agent: American Stock Transfer & Trust Company, LLC.
Refer to the SEC website for online version of financial documents or
December 31.
Deloitte & Touche, LLP.
A full list of Cardlytics’s Board of Directors is available on the Cardlytics Investor site, here:
Please fill the email alerts form to receive information about the company.